Secure Delivery of HIV-Related and Tuberculosis Laboratory Results to Patient Cell Phones: A Pilot Comparative Study.
South Africa processes 5.1 million HIV CD4, viral load (VL), and tuberculosis (TB) tests annually. This pilot non-randomized trial in South Africa explored an intervention ("MatlaMobile") to deliver laboratory results via mobile phone. Adults completing CD4, VL, and/or TB laboratory tests were enrol...
| Publicado en: | AIDS & Behavior Vol. 24; no. 12; pp. 3511 - 3522 |
|---|---|
| Autores principales: | , , , , , , , , , , , , |
| Formato: | research tables/charts Journal Article |
| Publicado: |
Springer Nature
Dec2020
|
| Acceso en línea: | Ver este registro en EBSCOhost |
| fields | @attributes: recordID: 1 pdfLink: plink: https://search.ebscohost.com/login.aspx?direct=true&db=ccm&AN=147000172&site=ehost-live header: @attributes: shortDbName: ccm uiTerm: 147000172 longDbName: CINAHL Complete uiTag: AN controlInfo: bkinfo: dissinfo: jinfo: jid: 10907165 G1T jtl: AIDS & Behavior issn: 10907165 maglogo: N pubinfo: dt: Dec2020 vid: 24 iid: 12 pid: 237 pub: Springer Nature place: New York, New York artinfo: ui: 147000172 143989687 147000172 147000172 10.1007/s10461-020-02912-3 147000172 ppf: 3511 ppct: 11 formats: fmt: – @attributes: type: T – @attributes: type: P tig: atl: Secure Delivery of HIV-Related and Tuberculosis Laboratory Results to Patient Cell Phones: A Pilot Comparative Study. aug: au: DiAndreth, Lisa Jarrett, Brooke A. Elf, Jessica L. Nishath, Thamanna Donville, Brennan Heidari, Omeid Cox, Sarah Moreton, Justine Ramnath, Aveer Lebina, Limakatso Variava, Ebrahim Golub, Jonathan E. Martinson, Neil A. affil: Johns Hopkins School of Nursing, 525 N Wolfe St., 21205, Baltimore, MD, USA sug: subj: Telehealth Methods Diagnosis, Laboratory HIV Infections Diagnosis Tuberculosis Diagnosis Cellular Phone Human South Africa Pilot Studies Comparative Studies Female Male Adult Middle Age Nonrandomized Trials Descriptive Statistics Adult: 19-44 years Middle Aged: 45-64 years Female Male ab: South Africa processes 5.1 million HIV CD4, viral load (VL), and tuberculosis (TB) tests annually. This pilot non-randomized trial in South Africa explored an intervention ("MatlaMobile") to deliver laboratory results via mobile phone. Adults completing CD4, VL, and/or TB laboratory tests were enrolled—either receiving results by returning to clinic (control, n = 174) or mobile phone (intervention, n = 226). Study staff instructed control participants to return within 6 days (standard-of-care). MatlaMobile instructed intervention participants with clinically actionable results requiring intervention or treatment change (i.e., < 200 CD4 cells per milliliter, ≥ 400 viral copies per milliliter, or TB positive) to return immediately. A greater proportion of intervention participants than controls saw their results within 7 days of enrollment (73% vs. 8.6%, p < 0.001). Among participants instructed to return, more intervention participants (20%, n = 14/70) returned than controls (8.6%, n = 15/174, p = 0.02). MatlaMobile demonstrated that patients can quickly receive and respond appropriately to digital delivery of health information. Resumen: Sudáfrica procesa 5.1 millones de pruebas de cuenta de CD4, carga viral de VIH (VL) y tuberculosis (TB) anualmente. En este estudio piloto no aleatorizado en Sudáfrica se exploró la intervención por medio de la aplicación ("MatlaMobile") para entregar resultados de laboratorio via teléfono celular. Adultos con pruebas de CD4, VL y/o TB, fueron incluidos para recibir los resultados cuando regresaron a la clínica (control, n = 174) o en su teléfono celular (intervención, n = 226). El staff del estudio instruyó a los participantes del grupo control a regresar en los primeros 6 días (práctica estándar). MatlaMobile instruyó a los participantes que necesitaban alguna intervención o ajuste al tratamiento, de acuerdo con sus resultados (i.e., CD4 < 200, VL ≥ 400, o TB +) a regresar inmediatamente a la clínica. Mayor proporción de participantes en el grupo de intervención, vs. control, vio sus resultados en los primeros 7 días (73% vs. 8.6%, p < 0.001). De los pacientes a los que se les pidió regresar, más participantes del grupo intervención (20%, n = 17/70) lo hicieron, comparados con el grupo control (8.6%, n = 15/174, p = 0.02). MatlaMobile demostró que los pacientes pueden recibir información de salud rápidamente de forma digital y responder de manera apropiada. pubtype: Academic Journal doctype: research tables/charts Journal Article ougenre: Article language: English refInfo: holdings: @attributes: islocal: N |
|---|